Trump Administration Promotes Leucovorin as Autism Treatment Amid Controversy

The Trump administration is advocating for leucovorin, an older generic drug, as a new treatment for autism, despite concerns from medical professionals about its efficacy. Many families had already tried the drug before the President's comments, reflecting the ongoing search for effective autism treatments and the influence of public figures on health discussions. This situation underscores the need for more rigorous studies to validate such treatments.